Epileptic seizures in diffuse low-grade gliomas in adults. 2014

Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
1 Department of Neurosurgery, Sainte-Anne Hospital, Paris, France.

Diffuse low-grade gliomas are highly epileptogenic brain tumours. We aimed to explore the natural course of epileptic seizures, their predictors and the prognostic significance of their occurrence in adult patients harbouring a diffuse low-grade glioma. An observational retrospective multicentre study examined 1509 patients with diffuse low-grade gliomas to identify mutual interactions between tumour characteristics, tumour course and epileptic seizures. At diagnosis, 89.9% of patients had epileptic seizures. Male gender (P = 0.003) and tumour location within functional areas (P = 0.001) were independent predictors of a history of epileptic seizures at diagnosis. Tumour volume, growth velocity, cortical location, histopathological subtype or molecular markers did not significantly affect epileptic seizure occurrence probability. Prolonged history of epileptic seizures (P < 0.001), insular location (P = 0.003) and tumour location close to functional areas (P = 0.038) were independent predictors of uncontrolled epileptic seizures at diagnosis. Occurrence of epileptic seizures (P < 0.001), parietal (P = 0.029) and insular (P = 0.002) locations were independent predictors of uncontrolled epileptic seizures after oncological treatment. Patient age (P < 0.001), subtotal (P = 0.007) and total (P < 0.001) resections were independent predictors of total epileptic seizure control after oncological treatment. History of epileptic seizures at diagnosis and total surgical resection were independently associated with increased malignant progression-free (P < 0.001 and P < 0.001) and overall (P < 0.001 and P = 0.016) survivals. Epileptic seizures are independently associated with diffuse low-grade glioma prognosis. Patients diagnosed with epileptic seizures and those with complete and early surgical resections have better oncological outcomes. Early and maximal surgical resection is thus required for diffuse low-grade gliomas, both for oncological and epileptological purposes.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
October 2011, Revue neurologique,
Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
November 2013, Journal of neurosurgery,
Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
October 2017, Seizure,
Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
October 2014, Diagnostic and interventional imaging,
Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
June 2006, The oncologist,
Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
July 2004, Current treatment options in neurology,
Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
December 2002, Current opinion in neurology,
Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
November 2011, Journal of neurosurgery,
Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
July 2008, Current treatment options in neurology,
Johan Pallud, and Etienne Audureau, and Marie Blonski, and Nader Sanai, and Luc Bauchet, and Denys Fontaine, and Emmanuel Mandonnet, and Edouard Dezamis, and Dimitri Psimaras, and Jacques Guyotat, and Philippe Peruzzi, and Philippe Page, and Beatriz Gal, and Eduardo Párraga, and Marie-Hélène Baron, and Michaela Vlaicu, and Rémy Guillevin, and Bertrand Devaux, and Hugues Duffau, and Luc Taillandier, and Laurent Capelle, and Gilles Huberfeld
November 2014, Praxis,
Copied contents to your clipboard!